# Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia

> **NCT00801814** · PHASE2,PHASE3 · COMPLETED · sponsor: **Glycemic Index Laboratories, Inc** · enrollment: 20 (actual)

## Conditions studied

- Blood Glucose, Postprandial

## Interventions

- **DIETARY_SUPPLEMENT:** PolyGlycopleX (PGX)
- **DIETARY_SUPPLEMENT:** PolyGlycopleX (PG)
- **DIETARY_SUPPLEMENT:** PolyGlycopleX
- **DIETARY_SUPPLEMENT:** Control
- **DIETARY_SUPPLEMENT:** Second Control

## Key facts

- **NCT ID:** NCT00801814
- **Lead sponsor:** Glycemic Index Laboratories, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-05
- **Final completion:** 2006-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2008-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00801814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00801814, "Effect of Escalating Doses of a Novel Viscous Polysaccharide on Postprandial Glycemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00801814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*